OrbiMed’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-336,300
Closed -$105M 124
2025
Q2
$105M Buy
336,300
+135,100
+67% +$51.6M 2.62% 12
2025
Q1
$105M Buy
201,200
+70,300
+54% +$35.9M 2.51% 10
2024
Q4
$66.2M Sell
130,900
-48,100
-27% -$27.3M 1.36% 24
2024
Q3
$105M Buy
179,000
+67,000
+60% +$37.9M 1.9% 14
2024
Q2
$57M Buy
112,000
+42,000
+60% +$20.6M 1.13% 28
2024
Q1
$34.6M Hold
70,000
0.63% 48
2023
Q4
$36.9M Hold
70,000
0.74% 46
2023
Q3
$35.3M Sell
70,000
-174,000
-71% -$85.6M 0.75% 49
2023
Q2
$117M Sell
244,000
-32,000
-12% -$15.6M 2.13% 10
2023
Q1
$130M Sell
276,000
-104,500
-27% -$50.4M 2.56% 10
2022
Q4
$202M Buy
380,500
+113,300
+42% +$60M 3.86% 2
2022
Q3
$135K Sell
267,200
-14,000
-5% -$7.36M 2.51% 8
2022
Q2
$144K Sell
281,200
-13,000
-4% -$6.53M 2.62% 8
2022
Q1
$150M Buy
294,200
+23,200
+9% +$11.2M 2.43% 9
2021
Q4
$136M Sell
271,000
-118,700
-30% -$53.7M 1.75% 16
2021
Q3
$152M Hold
389,700
1.67% 18
2021
Q2
$156M Sell
389,700
-13,300
-3% -$5.3M 1.58% 17
2021
Q1
$150M Buy
403,000
+12,700
+3% +$4.4M 1.4% 19
2020
Q4
$137M Buy
+390,300
New +$131M 1.2% 20
2019
Q1
Sell
-186,500
Closed -$46.5M 141
2018
Q4
$46.5M Hold
186,500
0.86% 40
2018
Q3
$49.6M Buy
186,500
+63,200
+51% +$16.4M 0.6% 51
2018
Q2
$30.3M Buy
+123,300
New +$29.6M 0.36% 65
2018
Q1
Sell
-239,500
Closed -$52.8M 148
2017
Q4
$52.8M Sell
239,500
-140,500
-37% -$29.8M 0.67% 46
2017
Q3
$74.4M Sell
380,000
-48,600
-11% -$9.39M 0.71% 41
2017
Q2
$79.5M Buy
428,600
+132,200
+45% +$23.2M 0.83% 39
2017
Q1
$48.6M Hold
296,400
0.55% 53
2016
Q4
$47.4M Sell
296,400
-315,400
-52% -$47.1M 0.6% 49
2016
Q3
$85.7M Sell
611,800
-596,400
-49% -$83.5M 0.98% 38
2016
Q2
$171M Buy
1,208,200
+396,200
+49% +$52.8M 1.78% 17
2016
Q1
$105M Buy
812,000
+574,000
+241% +$67.9M 1.1% 30
2015
Q4
$28M Hold
238,000
0.25% 66
2015
Q3
$27.6M Hold
238,000
0.28% 63
2015
Q2
$29M Buy
238,000
+3,000
+1% +$355K 0.24% 72
2015
Q1
$27.8M Hold
235,000
0.24% 68
2014
Q4
$23.8M Buy
235,000
+35,000
+18% +$3.32M 0.23% 69
2014
Q3
$17.3M Buy
+200,000
New +$16.9M 0.18% 81
2014
Q2
Sell
-102,000
Closed -$8.36M 145
2014
Q1
$8.36M Sell
102,000
-689,000
-87% -$51.9M 0.1% 100
2013
Q4
$59.6M Sell
791,000
-538,000
-40% -$38.6M 0.88% 34
2013
Q3
$95.2M Buy
1,329,000
+121,000
+10% +$8.66M 1.7% 22
2013
Q2
$79.1M Buy
+1,208,000
New +$75.2M 1.68% 22

Other funds holding UNH

OrbiMed's UNH Position: Q3 2025 in Review

OrbiMed sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 336,300 shares — an estimated $105M sold.

OrbiMed first reported a position in UNH in Q2 2013 and held it in 40 quarters. The position peaked at $202M in Q4 2022. 3,160 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • OrbiMed reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
  • OrbiMed sold 336,300 UnitedHealth shares in Q3 2025, an estimated $105M.
  • OrbiMed first reported a position in UnitedHealth in Q2 2013 and held it in 40 quarters.
  • OrbiMed's UnitedHealth position peaked at $202M in Q4 2022.
  • 3,160 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on OrbiMed's 13F filing for Q3 2025, filed 14 Nov 2025.